Journal of Nuclear Medicine
短名 | J Nucl Med |
Journal Impact | 9.25 |
国际分区 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING(Q1) |
期刊索引 | SCI Q1中科院 1 区 |
ISSN | 0161-5505, 1535-5667, 2159-662X |
h-index | 239 |
国内分区 | 医学(1区)医学核医学(2区) |
Top期刊 | 是 |
核医学杂志 (JNM) — 由非营利性国际科学和专业组织核医学和分子成像学会 (SNMMI) 自行出版 — 为全球读者提供临床调查、基础科学报告、继续教育文章、书评、就业机会以及实践和研究中快速变化的问题的最新情况。
期刊主页投稿网址涉及主题 | 医学生物内科学核医学放射科化学遗传学物理心理学病理生物化学外科神经科学内分泌学计算机科学 |
出版信息 | 出版商: Society of Nuclear Medicine Inc.,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1960,原创研究文献占比: 98.50%,自引率:8.80%, Gold OA占比: 19.00% |
平均审稿周期 | 网友分享经验:平均1.0个月 |
平均录用比例 | 网友分享经验:很难 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
[<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
2024-9-12
Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis
2024-9-12
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting
2024-9-12
Design, Synthesis, and Preclinical Evaluation of a High-Affinity<sup>18</sup>F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction
2024-9-12
Quantitative SPECT/CT Metrics in Early Prediction of [<sup>177</sup>Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients
2024-9-12
Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT
2024-9-12
Dual Somatostatin Receptor/<sup>18</sup>F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors
2024-9-12
Preclinical Evaluation of<sup>177</sup>Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
2024-9-12
Nuclear Imaging of Bispecific Antibodies on the Rise
2024-9-12
Development of<sup>18</sup>F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance
2024-9-12
The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice
2024-9-5
First-in-Human Total-Body PET/CT Imaging Using<sup>89</sup>Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
2024-9-5
Evaluating the Utility of<sup>18</sup>F-FDG PET/CT in Cancer of Unknown Primary
2024-9-5
C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
2024-9-5
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer
2024-9-5
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [<sup>18</sup>F]PSMA-1007 PET/CT
2024-9-5
Improving<sup>18</sup>F-FDG PET Quantification Through a Spatial Normalization Method
2024-8-29
Association Between CA 15-3 and<sup>18</sup>F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya
2024-8-29
The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for<sup>161</sup>Tb Compared with<sup>177</sup>Lu with a Higher Dose Response for [<sup>161</sup>Tb]Tb-DOTA-LM3 Than for [<sup>161</sup>Tb]Tb-DOTATATE
2024-8-29
Navigating the Future of Prostate Cancer Care: AI-Driven Imaging and Theranostics Through the Lens of RELAINCE
2024-8-29
1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
2024-8-21
Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
2024-8-14
Theranostic Intratumoral Convection-Enhanced Delivery of<sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
2024-8-14
Single Chelator–Minibody Theranostic Agents for<sup>89</sup>Zr PET Imaging and<sup>177</sup>Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
2024-8-14
The Costs to Our Patients
2024-8-14
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
2024-8-14
<sup>177</sup>Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
2024-8-8
[<sup>68</sup>Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria
2024-8-8
Impact of Posttreatment SPECT/CT on Patient Management During<sup>177</sup>Lu-PSMA-617 Radiopharmaceutical Therapy
2024-8-8
Neurologic Symptoms After<sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
2024-8-1
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
2024-8-1
<sup>18</sup>F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology
2024-8-1
Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
2024-8-1
Utility of<sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on<sup>68</sup>Ga-PSMA-11 PET/CT
2024-8-1
Total-Body Dynamic Imaging and Kinetic Modeling of [<sup>18</sup>F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
2024-8-1
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline<sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation
2024-8-1
Role of<sup>64</sup>CuCl<sub>2</sub>PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and<sup>18</sup>F-FDG PET/CT
2024-7-25
Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras
2024-7-25
Reply; The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
2024-7-25
The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
2024-7-25
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
2024-7-25
Development of a<sup>213</sup>Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates
2024-7-25
Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions
2024-7-25
Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of<sup>225</sup>Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
2024-7-25
FINDing the Future of Radiopharma
2024-7-25
Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions
2024-7-25
Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study
2024-7-18
<i>h</i>HEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery
2024-7-18
StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions
2024-7-18
<sup>211</sup>At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation
2024-7-18
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远